SLC37A2, also known as Sodium-Dependent Phosphate Transporter 2 (NaPi-2b), is a gene that codes for a protein involved in the transport of inorganic phosphate ions (Pi) across cell membranes. This protein plays a crucial role in maintaining phosphate homeostasis within the body, a process vital for various physiological functions, including bone formation, energy metabolism, and DNA synthesis.The SLC37A2 gene is primarily expressed in the renal (kidney) tubules, where it is responsible for the reabsorption of phosphate from the urine back into the bloodstream. This reabsorption mechanism is essential for conserving phosphate, as it is an essential mineral required for the formation of hydroxyapatite crystals in bone and teeth, as well as for various cellular processes.
Mutations or dysregulation of SLC37A2 can lead to disorders related to phosphate metabolism, such as hypophosphatemia (low levels of phosphate in the blood). Hypophosphatemia can result in weakened bones, muscle weakness, and other health issues.SLC37A2's role in phosphate transport is particularly important in the context of disorders like X-linked hypophosphatemia (XLH), which is characterized by impaired renal phosphate reabsorption due to mutations in genes related to phosphate transport. SLC37A2 research is critical for understanding the molecular basis of such disorders and developing potential interventions.Furthermore, SLC37A2 has implications beyond phosphate transport, as it is also involved in glucose metabolism and glycogen synthesis. Its precise functions in these processes are areas of active research.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA could enhance SLC37A2 expression by activating protein kinase C, playing a role in cellular immune responses. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone could modulate SLC37A2 expression, affecting glucose-6-phosphate transport in immune-related processes. | ||||||
Hydrocortisone | 50-23-7 | sc-300810 | 5 g | $102.00 | 6 | |
Hydrocortisone might influence SLC37A2 expression, impacting metabolic and immune cell responses. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin could stimulate SLC37A2 expression, influencing glucose homeostasis and cellular metabolic activities. | ||||||
1,1-Dimethylbiguanide, Hydrochloride | 1115-70-4 | sc-202000F sc-202000A sc-202000B sc-202000C sc-202000D sc-202000E sc-202000 | 10 mg 5 g 10 g 50 g 100 g 250 g 1 g | $20.00 $43.00 $63.00 $156.00 $260.00 $510.00 $31.00 | 37 | |
Metformin might enhance SLC37A2 expression, affecting glucose-6-phosphate transport and overall glucose metabolism. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Pioglitazone could upregulate SLC37A2, influencing pathways related to glucose metabolism and insulin sensitivity. | ||||||
Berberine | 2086-83-1 | sc-507337 | 250 mg | $92.00 | 1 | |
Berberine may increase SLC37A2 expression, modulating glucose-6-phosphate transport and metabolic responses in cells. | ||||||